Knockdown of swine leukocyte antigen expression in porcine lung transplants enables graft survival without immunosuppression.
Animals
Lung Transplantation
Swine
Graft Survival
/ immunology
Histocompatibility Antigens Class I
/ metabolism
Gene Knockdown Techniques
Immunosuppression Therapy
Graft Rejection
/ immunology
Swine, Miniature
Histocompatibility Antigens Class II
/ metabolism
Transplantation, Homologous
beta 2-Microglobulin
/ genetics
Lung
/ metabolism
Nuclear Proteins
Trans-Activators
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
17 Jul 2024
17 Jul 2024
Historique:
medline:
17
7
2024
pubmed:
17
7
2024
entrez:
17
7
2024
Statut:
ppublish
Résumé
Immune rejection remains the major obstacle to long-term survival of allogeneic lung transplants. The expression of major histocompatibility complex molecules and minor histocompatibility antigens triggers allogeneic immune responses that can lead to allograft rejection. Transplant outcomes therefore depend on long-term immunosuppression, which is associated with severe side effects. To address this problem, we investigated the effect of genetically engineered transplants with permanently down-regulated swine leukocyte antigen (SLA) expression to prevent rejection in a porcine allogeneic lung transplantation (LTx) model. Minipig donor lungs with unmodified SLA expression (control group,
Identifiants
pubmed: 39018368
doi: 10.1126/scitranslmed.adi9548
doi:
Substances chimiques
swine leukocyte antigen
0
Histocompatibility Antigens Class I
0
Histocompatibility Antigens Class II
0
beta 2-Microglobulin
0
MHC class II transactivator protein
0
Nuclear Proteins
0
Trans-Activators
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM